GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (OTCPK:LMLLF) » Definitions » YoY EPS Growth

Pharmadrug (Pharmadrug) YoY EPS Growth : 66.67% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Pharmadrug YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Pharmadrug's YoY EPS Growth for the quarter that ended in Sep. 2023 was 66.67%.

Pharmadrug's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.00.


Pharmadrug YoY EPS Growth Historical Data

The historical data trend for Pharmadrug's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug YoY EPS Growth Chart

Pharmadrug Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,624.56 83.25 56.88 95.77 -1,388.89

Pharmadrug Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.45 -116.13 82.14 90.43 66.67

Pharmadrug YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Pharmadrug's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(-0.134--0.009)/ | -0.009 |
=-1,388.89 %

Pharmadrug's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EPS Growth (Q: Sep. 2023 )
=(Earnings per Share (Diluted) (Q: Sep. 2023 )-Earnings per Share (Diluted) (Q: Sep. 2022 )) / | Earnings per Share (Diluted) (Q: Sep. 2022 )) |
=(-0.004--0.012)/ | -0.012 |
=66.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmadrug YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Pharmadrug's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmadrug (Pharmadrug) Business Description

Traded in Other Exchanges
Address
77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Pharmadrug (Pharmadrug) Headlines